Esperion Therapeutics SG&A Expense (Quarterly) Insights

Esperion Therapeutics Inc (ESPR)

2.08 +0.02 (+0.97%) USD | NASDAQ | May 03, 16:00

2.08 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	45.42M
September 30, 2023	33.24M
June 30, 2023	33.96M
March 31, 2023	29.90M
December 31, 2022	24.14M
September 30, 2022	24.95M
June 30, 2022	29.61M
March 31, 2022	30.38M
December 31, 2021	38.34M
September 30, 2021	39.26M
June 30, 2021	46.32M
March 31, 2021	61.06M
December 31, 2020	61.56M
September 30, 2020	48.83M
June 30, 2020	47.68M
March 31, 2020	41.55M
December 31, 2019	21.71M
September 30, 2019	18.47M
June 30, 2019	13.49M
March 31, 2019	12.18M
December 31, 2018	11.18M
September 30, 2018	9.011M
June 30, 2018	6.956M
March 31, 2018	5.954M

Date	Value
December 31, 2017	5.257M
September 30, 2017	5.681M
June 30, 2017	5.412M
March 31, 2017	5.029M
December 31, 2016	4.404M
September 30, 2016	4.214M
June 30, 2016	4.633M
March 31, 2016	5.031M
December 31, 2015	5.278M
September 30, 2015	5.672M
June 30, 2015	5.253M
March 31, 2015	4.035M
December 31, 2014	3.18M
September 30, 2014	2.526M
June 30, 2014	2.726M
March 31, 2014	2.49M
December 31, 2013	2.398M
September 30, 2013	1.924M
June 30, 2013	1.172M
March 31, 2013	1.251M
December 31, 2012	0.5061M
September 30, 2012	0.5338M
June 30, 2012	0.5337M
March 31, 2012	0.6324M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

13.49M

Minimum

Jun 2019

61.56M

Maximum

Dec 2020

36.31M

Average

33.96M

Median

Jun 2023

SG&A Expense (Quarterly) Benchmarks